Dorchester Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.31M Sell
14,158
-200
-1% -$18.5K 0.26% 62
2024
Q3
$1.2M Sell
14,358
-200
-1% -$16.8K 0.22% 68
2024
Q2
$999K Sell
14,558
-1,240
-8% -$85.1K 0.19% 73
2024
Q1
$1.16M Sell
15,798
-170
-1% -$12.5K 0.21% 76
2023
Q4
$1.29M Sell
15,968
-378
-2% -$30.6K 0.24% 64
2023
Q3
$1.22M Buy
16,346
+13,406
+456% +$1M 0.25% 64
2023
Q2
$227K Sell
2,940
-30
-1% -$2.31K 0.05% 134
2023
Q1
$246K Sell
2,970
-990
-25% -$82.1K 0.05% 137
2022
Q4
$340K Sell
3,960
-740
-16% -$63.5K 0.08% 113
2022
Q3
$290K Sell
4,700
-300
-6% -$18.5K 0.06% 126
2022
Q2
$309K Buy
5,000
+1,710
+52% +$106K 0.06% 126
2022
Q1
$244K Buy
3,290
+100
+3% +$7.42K 0.04% 146
2021
Q4
$232K Buy
3,190
+50
+2% +$3.64K 0.05% 136
2021
Q3
$219K Hold
3,140
0.05% 137
2021
Q2
$216K Buy
+3,140
New +$216K 0.05% 145
2020
Q1
Sell
-81,078
Closed -$5.27M 122
2019
Q4
$5.27M Buy
81,078
+610
+0.8% +$39.6K 1.47% 28
2019
Q3
$5.1M Buy
80,468
+10
+0% +$634 1.5% 26
2019
Q2
$5.44M Buy
80,458
+90
+0.1% +$6.08K 1.61% 24
2019
Q1
$5.23M Buy
80,368
+1,739
+2% +$113K 1.59% 25
2018
Q4
$4.92M Sell
78,629
-9
-0% -$563 1.71% 22
2018
Q3
$6.07M Buy
78,638
+13,835
+21% +$1.07M 1.89% 19
2018
Q2
$4.59M Sell
64,803
-2,050
-3% -$145K 1.51% 25
2018
Q1
$5.04M Sell
66,853
-560
-0.8% -$42.2K 1.7% 21
2017
Q4
$4.83M Sell
67,413
-2,245
-3% -$161K 1.53% 23
2017
Q3
$5.64M Buy
69,658
+1,048
+2% +$84.9K 1.81% 17
2017
Q2
$4.86M Buy
68,610
+196
+0.3% +$13.9K 1.67% 21
2017
Q1
$4.65M Buy
68,414
+5,065
+8% +$344K 1.62% 24
2016
Q4
$4.54M Buy
63,349
+1,904
+3% +$136K 1.65% 22
2016
Q3
$4.86M Buy
61,445
+2,630
+4% +$208K 1.81% 20
2016
Q2
$4.91M Buy
58,815
+24,280
+70% +$2.03M 1.82% 18
2016
Q1
$3.17M Buy
34,535
+22,460
+186% +$2.06M 1.2% 30
2015
Q4
$1.22M Buy
12,075
+4,625
+62% +$468K 0.51% 48
2015
Q3
$974K Buy
7,450
+2,400
+48% +$314K 0.36% 50
2015
Q2
$738K Buy
+5,050
New +$738K 0.24% 63